Document Detail


Doxorubicin cytotoxicity to P388 lymphocytic leukemia as determined by alkaline elution and established assays.
MedLine Citation:
PMID:  3813486     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Very large variations exist in the response of individual tumors to antineoplastic agents, even when the tumors are apparently very similar from the point of view of stage and histological classification. It has been recognized for a long time that methods capable of revealing the specific chemosensitivity of individual tumors could be useful for an individual optimization of a chemotherapeutic protocol. The Tumor Colony Forming Assay (TCFA) and the Biochemical Antimetabolic Assay (BAA) have been proposed for this purpose. Their main limitation is a consequence of the fact that the capability of in vitro growth is required from cells of a tumor grown in vivo. This is often lacking or very poor in the first in vitro passages. In this work we have investigated the possibility of using a sensitive method for evaluating DNA damage, the Alkaline Elution technique (AE). Cells treated in vivo can be easily tested directly for DNA damage. No cell proliferation in vitro is required. It is not required that the measured effect is the specific cause of cell death. A P388 Doxorubicin sensitive line and a resistant subline were tested. Correct correlations between DNA damage and chemosensitivity were obtained working both in vivo and in vitro. This test could be useful for assessing the chemosensitivity in vivo of alkylating and intercalating agents.
Authors:
P Russo; R E Favoni; D Zarcone; L Miglietta; M Peluso; A Nicolin; F Bignone; S Parodi
Related Documents :
21331626 - Adenosine 5'-triphosphate-sensitive potassium channel activator induces the up-regulati...
8799456 - Investigation of the effect of anti-neoplastic drugs, cyclophosphamide, cisplatin and m...
21743496 - Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, fibulin...
23450706 - Pediatric glioma stem cells: biologic strategies for oncolytic hsv virotherapy.
9363866 - Cd30 ligand in lymphoma patients with cd30+ tumors.
1595066 - Leiomyosarcoma of the small intestine associated with von recklinghausen's disease: rep...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anticancer research     Volume:  6     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    1986 Nov-Dec
Date Detail:
Created Date:  1987-03-18     Completed Date:  1987-03-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  1297-304     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
DNA Damage
Doxorubicin / therapeutic use*
Drug Evaluation, Preclinical / methods*
Female
Leukemia P388 / drug therapy*
Leukemia, Experimental / drug therapy*
Mice
Tumor Stem Cell Assay
Chemical
Reg. No./Substance:
23214-92-8/Doxorubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Different techniques for drug cytotoxicity evaluation on MCF-7 human breast cancer cell line.
Next Document:  Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grad...